Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma

Bone Marrow Transplantation
C JoaoS N Markovic

Abstract

Autologous stem cell transplantation (ASCT) is an effective treatment strategy for mantle-cell lymphoma (MCL) demonstrating significantly prolonged progression-free survival (PFS) when compared to interferon-alpha maintenance therapy of patients in first remission. The study of absolute lymphocyte count at day 15 (ALC-15) after ASCT as a prognostic factor in non-Hodgkin lymphoma (NHL) included different lymphoma subtypes. The relationship of ALC-15 after ASCT in MCL has not been specifically addressed. We evaluated the impact of ALC-15 recovery on survival of MCL patients undergoing ASCT. We studied 42 consecutive MCL patients who underwent ASCT at the Mayo Clinic in Rochester from 1993 to 2005. ALC-15 threshold was set at 500 cells/microl. The median follow-up after ASCT was 25 months (range, 2-106 months). The median overall survival (OS) and PFS times were significantly better for the 24 patients who achieved an ALC-15 >or=500 cells/microl compared with 18 patients with ALC-15 <500 cells/microl (not reached vs 30 months, P<0.01 and not reached vs 16 months, P<0.0006, respectively). Multivariate analysis demonstrated ALC-15 to be an independent prognostic factor for OS and PFS. The ALC-15 >or=500 cells/microl is associated wi...Continue Reading

References

May 14, 1982·JAMA : the Journal of the American Medical Association·F E HarrellR A Rosati
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G A VeldersJ H Van Krieken
Aug 11, 1998·Leukemia·H SamahaB Coiffier
Feb 16, 2000·Bone Marrow Transplantation·D DecaudinC Gisselbrecht
Dec 29, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J M VoseJ O Armitage
Aug 3, 2002·Leukemia & Lymphoma·Riikka OinonenErkki Elonen
Jul 1, 1957·British Journal of Haematology·D W BARNES, J F LOUTIT
Apr 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cristina JoãoMarilia Cascalho
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yago NietoRoy B Jones

❮ Previous
Next ❯

Citations

Dec 7, 2006·Cancer Immunology, Immunotherapy : CII·Melinda S MerchantCrystal L Mackall
May 7, 2013·Bone Marrow Transplantation·A L GarfallE A Stadtmauer
Apr 1, 2008·Nature Biotechnology·Johannes L ZakrzewskiMarcel R M van den Brink
Apr 21, 2012·Current Opinion in Hematology·Mark BoschJan Storek
Jul 9, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stuart A GrossmanUNKNOWN NABTT CNS Consortium
May 24, 2011·World Journal of Clinical Oncology·Luis F Porrata, Svetomir N Markovic
Jun 1, 2012·Clinical & Developmental Immunology·Ivetta DanyleskoArnon Nagler
Jan 31, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Luis F PorrataSvetomir N Markovic
Sep 17, 2011·Pathology·L Bik ToIan D Lewis
Aug 25, 2011·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·A Anoceto MartínezL González
Jun 23, 2009·Trends in Immunology·Heather E LynchGregory D Sempowski
Oct 30, 2007·Seminars in Immunology·Gabrielle L GoldbergMarcel R M van den Brink
Jul 22, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Luis F PorrataSvetomir N Markovic
Apr 17, 2007·British Journal of Haematology·Deepti BehlLuis F Porrata
Mar 19, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jessica RueffMartin Stern
Dec 7, 2013·Clinical Lymphoma, Myeloma & Leukemia·Ivetta DanyleskoArnon Nagler
Dec 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Devendra K HiwaseAnthony P Schwarer
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Dec 4, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stefan O CiureaRichard E Champlin
Jun 11, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Luis F PorrataSvetomir N Markovic
Sep 17, 2016·Advances in Hematology·Luis F Porrata
Jun 16, 2017·Journal of Hematology & Oncology·Aurélie TormoMoutih Rafei

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.